Reference Hub: Treatment for severe Progressive Multifocal Leukoencephalopathy after Tysabri

This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.

Primary topic reference

Treatment for severe Progressive Multifocal Leukoencephalopathy after Tysabri Resource Guide — detailed background and analysis.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

World Health Organization (WHO)

Reference: World Health Organization (WHO)

Authoritative source for clinical, regulatory, and public-health background reading.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.